PALO ALTO, Calif.--(BUSINESS WIRE)--Nov 19, 2026--
HTEC, the global AI technology and engineering leader, today released new research examining how healthcare and life sciences organizations measure, track, and realize value from AI investments, as well as the risks and barriers preventing them from doing so at scale. The findings reveal that while investment continues to rise, organizations that successfully scale AI focus not only on technology, but also on the governance, workforce adoption, and operational foundations needed to track, prove, and realize impact.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119322683/en/
The HTEC AI Value Realization Report 2026: Healthcare & Life Sciences found that among healthcare respondents currently pursuing AI adoption, 83% report increasing AI investment over the past year. Yet despite that momentum, only 41% describe their organizations as scaling AI or already AI-native, indicating that increased spending alone does not guarantee mature adoption.
The findings reflect the distinctive challenges of healthcare and life sciences, where AI must operate within complex clinical, operational, and regulatory environments.
"Healthcare leaders are not evaluating AI on speed alone. They need evidence that outcomes are reliable, repeatable, and appropriate for the level of risk involved, whether the application supports research, operations, or patient care," said Nemanja Kovačev, Head of Healthcare and Life Sciences Practice at HTEC. "Investment is growing, but long-term value depends on governance, validation, and the ability to integrate AI into everyday workflows without creating additional burden for the people using it."
Faster delivery matters, but proof of value matters more
When asked which outcomes matter most from AI investment, healthcare respondents most frequently cited faster time-to-market and delivery speed (32%), followed closely by improved customer experience (28%), innovation (27%), and risk reduction and compliance improvement (26%). By comparison, cost reduction ranked considerably lower at 18%.
These findings suggest that healthcare leaders increasingly view AI as a strategic enabler of growth, innovation, and operational improvement rather than simply a means of reducing costs. The close spread across these priorities suggests that value in healthcare is multidimensional, encompassing speed, experience, innovation, and risk management rather than being defined by a single outcome.
Measuring value, however, remains a challenge. Organizations continue to face difficulties quantifying long-term or indirect benefits, while limitations in analytics and telemetry can make it harder to track AI's impact consistently.
Data quality and availability also remain persistent obstacles, limiting visibility into outcomes and making it more difficult to connect investment, usage, and realized value. Together, these findings suggest that while healthcare organizations increasingly recognize AI's potential, many are still building the capabilities needed to measure and scale that value effectively.
AI governance reflects healthcare's diverse risk landscape
The research also highlights significant variation in how organizations assess AI risk.
More than half of healthcare respondents ( 55% ) say AI risk is considered informally alongside value, while just 11% report measuring risk consistently across their AI portfolios.
Rather than indicating a lack of governance, the findings reflect the reality that healthcare AI applications carry very different risk profiles, from administrative support tools to systems that influence clinical decisions.
The research also found that requiring human approval before every AI action is most common in Saudi Arabia (46%) and the UK (35%), illustrating different approaches to oversight across markets.
People and processes remain the biggest barriers
Perhaps the strongest finding in the report is that healthcare organizations increasingly see operational challenges, rather than technical limitations, as the primary obstacle to realizing AI value. Some 86% of respondents agree that people and processes constrain AI value more than technology, with poor data quality, resistance to change, and limited workforce enablement emerging as key barriers. Only 24% of organizations provide comprehensive AI enablement for non-technical employees.
"Achieving value at scale requires more than deploying AI tools. Organizations must also prepare workforces, adapt workflows, establish accountability, and build confidence among employees expected to use AI in their daily work," said Alfred Olivares, Global Managing Partner, Healthcare and Life Sciences.
Turning investment into dependable outcomes
Taken together, the findings suggest that the next phase of AI adoption in healthcare and life sciences will be defined by execution rather than experimentation. As organizations move beyond pilots, success will increasingly depend on strong data foundations, effective oversight, workforce readiness, and clear accountability across the AI lifecycle.
For HTEC, this reinforces the growing need for partners that can help organizations navigate strategy, validation, implementation, and regulatory requirements while scaling AI responsibly in highly regulated environments.
About the Research
The findings are based on responses from 213 healthcare and life sciences executives within a global survey of 1,500 senior decision-makers across the United States, United Kingdom, Germany, Saudi Arabia, and the United Arab Emirates. The research was commissioned by HTEC and conducted by Censuswide in July 2026.
The full HTEC AI Value Realization Report 2026: Healthcare & Life Sciences is available at the LINK.
About HTEC
HTEC Group Inc. is a global technology and engineering company that helps organizations build AI capabilities from silicon to outcomes. HTEC helps its customers build an adaptive, vendor-agnostic AI stack designed to evolve as technologies, models, and platforms change.
Through its forward-deployed model, HTEC works alongside customer’s teams to connect AI to business strategy and create a repeatable capability consistently and faster each time. OneLoopAi is at the heart of this approach and brings greater transparency in measuring progress and continuously improves how AI is developed and deployed. The result is a stronger path from AI investment to measurable business value and AI at scale.
With more than 15 years of experience working with AI and machine learning, HTEC combines deep engineering expertise with strategy, product, design, and data capabilities to turn AI ambition into production.
HTEC research finds 83% of healthcare and life sciences organizations have increased AI investment, yet adoption is still shaped by regulatory complexity, validation requirements, and organizational readiness.
